Literature DB >> 13662650

Heparin-like anticoagulant occurring in association with chronic nephritis.

A I CETINGIL, O N ULUTIN, M KARACA.   

Abstract

Entities:  

Keywords:  HEMORRHAGIC DIATHESIS/complications; HEPARIN/in blood; NEPHRITIS/complications

Mesh:

Substances:

Year:  1959        PMID: 13662650      PMCID: PMC1989802          DOI: 10.1136/bmj.2.5140.38

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  [Isolated factor V deficiency caused by a specific inhibitor].

Authors:  M H HORDER
Journal:  Acta Haematol       Date:  1955-04       Impact factor: 2.195

2.  Antiaccelerator (anticonvertin) activity of canine plasma and serum.

Authors:  R H WAGNER; W M BRANNAN; K M BRINKHOUS
Journal:  Proc Soc Exp Biol Med       Date:  1955-06

3.  The action of heparin in the prevention of prothrombin conversion.

Authors:  A S DOUGLAS
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

4.  Anti-AcG: specific circulating inhibitor of the labile clotting factor.

Authors:  J H FERGUSON; C L JOHNSTON; D A HOWELL
Journal:  Proc Soc Exp Biol Med       Date:  1957-07

5.  [Study of hypercoagulability].

Authors:  O N ULUTIN; D SESTAKOF
Journal:  Turk Tip Cemiy Mecm       Date:  1957-12
  5 in total
  3 in total

1.  A circulating anticoagulant occurring after temporal arteritis and controlled by corticosteroid therapy.

Authors:  A G WHITFIELD; M J MEYNELL; B M FESSEY; W A HUDSON
Journal:  J Clin Pathol       Date:  1962-07       Impact factor: 3.411

Review 2.  Abnormalities of haemostasis in renal failure.

Authors:  M S Losowsky; W D Walls
Journal:  J R Coll Physicians Lond       Date:  1971-01

3.  Acquired heparin-like anticoagulation process in a patient with multiple myeloma: a case report and literature review.

Authors:  Haorui Shen; Chao Wu; Lijuan Chen; Run Zhang
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.